• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有CXC趋化因子受体4激动剂和拮抗剂活性的基质细胞衍生因子-1的N端肽段。

N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.

作者信息

Loetscher P, Gong J H, Dewald B, Baggiolini M, Clark-Lewis I

机构信息

Theodor-Kocher Institute, University of Bern, CH 3000 Bern, Switzerland.

出版信息

J Biol Chem. 1998 Aug 28;273(35):22279-83. doi: 10.1074/jbc.273.35.22279.

DOI:10.1074/jbc.273.35.22279
PMID:9712844
Abstract

Peptides corresponding to the N-terminal 9 residues of stromal cell-derived factor-1 (SDF-1) have SDF-1 activity. SDF-1, 1-8, 1-9, 1-9 dimer, and 1-17 induced intracellular calcium and chemotaxis in T lymphocytes and CEM cells and bound to CXC chemokine receptor 4 (CXCR4). The peptides had similar activities to SDF-1 but were less potent. Whereas native SDF-1 had half-maximal chemoattractant activity at 5 nM, the 1-9 dimer required 500 nM and was therefore 100-fold less potent. The 1-17 and a 1-9 monomer analog were 4- and 36-fold, respectively, less potent than the 1-9 dimer. Both the chemotactic and calcium response of the 1-9 dimer was inhibited by an antibody to CXCR4. The basis for the enhanced activity of the dimer form of SDF-1, 1-9 is uncertain, but it could involve an additional fortuitous binding site on the 1-9 peptide in addition to the normal SDF-1, 1-9 site. A 1-9 analog, 1-9[P2G] dimer, was found to be a CXCR4 antagonist. Overall this study shows that the N-terminal peptides are CXCR4 agonists or antagonists, and these could be leads for high affinity ligands.

摘要

与基质细胞衍生因子-1(SDF-1)N端9个残基对应的肽段具有SDF-1活性。SDF-1、1-8、1-9、1-9二聚体和1-17可诱导T淋巴细胞和CEM细胞内的钙离子流动及趋化作用,并与CXC趋化因子受体4(CXCR4)结合。这些肽段具有与SDF-1相似的活性,但效力较低。天然SDF-1在5 nM时具有半数最大趋化活性,而1-9二聚体则需要500 nM,因此效力低100倍。1-17和1-9单体类似物的效力分别比1-9二聚体低4倍和36倍。1-9二聚体的趋化和钙离子反应均被抗CXCR4抗体抑制。SDF-1 1-9二聚体形式活性增强的原因尚不确定,但除了正常的SDF-1 1-9位点外,可能还涉及1-9肽段上一个额外的偶然结合位点。一种1-9类似物1-9[P2G]二聚体被发现是一种CXCR4拮抗剂。总体而言,这项研究表明N端肽段是CXCR4激动剂或拮抗剂,这些可能是高亲和力配体的先导物。

相似文献

1
N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.具有CXC趋化因子受体4激动剂和拮抗剂活性的基质细胞衍生因子-1的N端肽段。
J Biol Chem. 1998 Aug 28;273(35):22279-83. doi: 10.1074/jbc.273.35.22279.
2
The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.用合成肽探究带正电荷残基在CXCR4识别中的作用。
Biochem Biophys Res Commun. 1999 Oct 5;263(3):691-5. doi: 10.1006/bbrc.1999.1441.
3
C-terminal cyclization of an SDF-1 small peptide analogue dramatically increases receptor affinity and activation of the CXCR4 receptor.SDF-1小肽类似物的C端环化显著提高了受体亲和力和CXCR4受体的激活。
J Med Chem. 2002 May 9;45(10):2024-31. doi: 10.1021/jm0104015.
4
Pharmacological properties of peptides derived from stromal cell-derived factor 1: study on human polymorphonuclear cells.基质细胞衍生因子1衍生肽的药理学特性:对人多形核细胞的研究
Mol Pharmacol. 2001 Jun;59(6):1418-25. doi: 10.1124/mol.59.6.1418.
5
Structural determinants of unexpected agonist activity in a retro-peptide analogue of the SDF-1alpha N-terminus.基质细胞衍生因子-1α(SDF-1α)N端反向肽类似物中意外激动剂活性的结构决定因素。
FEBS Lett. 2005 Oct 10;579(24):5293-8. doi: 10.1016/j.febslet.2005.07.100.
6
Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).趋化因子基质细胞衍生因子-1α(SDF-1α/CXCL12)对CXCR4硫酸化酪氨酸的识别。
J Mol Biol. 2006 Jun 23;359(5):1400-9. doi: 10.1016/j.jmb.2006.04.052. Epub 2006 May 11.
7
Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists.CXCR4与SDF-1α复杂多位点相互作用的药理学证据:对选择性CXCR4拮抗剂开发的启示
Immunol Lett. 2001 Aug 1;78(1):29-34. doi: 10.1016/s0165-2478(01)00228-0.
8
Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.SDF-1衍生小肽的信号传导特性与抗病毒特性的解离
Curr Biol. 1998 Mar 26;8(7):369-76. doi: 10.1016/s0960-9822(98)70155-1.
9
Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.趋化因子SDF-1/CXCL12对CXCR4磺基酪氨酸的识别的结构基础
Sci Signal. 2008 Sep 16;1(37):ra4. doi: 10.1126/scisignal.1160755.
10
Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.克隆及鉴定突变型人基质细胞衍生因子-1(SDF-1):SDF-1α的C末端α-螺旋在CXCR4激活及信号传导中起关键作用,但对CXCR4结合亲和力无影响。
Exp Hematol. 2006 Nov;34(11):1553-62. doi: 10.1016/j.exphem.2006.07.001.

引用本文的文献

1
Triazolothiadiazine derivative positively modulates CXCR4 signaling and improves diabetic wound healing.三氮噻二嗪衍生物正向调节 CXCR4 信号,改善糖尿病创面愈合。
Biochem Pharmacol. 2023 Oct;216:115764. doi: 10.1016/j.bcp.2023.115764. Epub 2023 Aug 25.
2
Computational design of dynamic receptor-peptide signaling complexes applied to chemotaxis.基于动态受体-肽信号复合物的计算设计及其在趋化作用中的应用。
Nat Commun. 2023 May 19;14(1):2875. doi: 10.1038/s41467-023-38491-9.
3
Endogenous Peptide Inhibitors of HIV Entry.HIV 进入的内源性肽抑制剂。
Adv Exp Med Biol. 2022;1366:65-85. doi: 10.1007/978-981-16-8702-0_5.
4
Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor.肽激动剂与CXCR4趋化因子受体结合的机制
Front Mol Biosci. 2022 Mar 11;9:821055. doi: 10.3389/fmolb.2022.821055. eCollection 2022.
5
Discovery of Small Molecule Activators of Chemokine Receptor CXCR4 That Improve Diabetic Wound Healing.发现小分子激动剂 Chemokine Receptor CXCR4,可改善糖尿病创面愈合。
Int J Mol Sci. 2022 Feb 16;23(4):2196. doi: 10.3390/ijms23042196.
6
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.CXCL14 优先与稳态趋化因子受体系统协同作用。
Front Immunol. 2020 Oct 5;11:561404. doi: 10.3389/fimmu.2020.561404. eCollection 2020.
7
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.N-端修饰的 CXCL12 趋化因子在 CXCR4 和 ACKR3 受体上的差异活性和选择性。
J Leukoc Biol. 2020 Jun;107(6):1123-1135. doi: 10.1002/JLB.2MA0320-383RR. Epub 2020 May 6.
8
Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.趋化因子 N 端特征的不同贡献证明了与 CXCR4 和 CXCR3 相比,趋化因子具有不同的配体结合模式和偏向于激活 ACKR3/CXCR7 的特点。
Br J Pharmacol. 2018 May;175(9):1419-1438. doi: 10.1111/bph.14132. Epub 2018 Mar 23.
9
Epithelial chemokine CXCL14 synergizes with CXCL12 allosteric modulation of CXCR4.上皮趋化因子CXCL14与CXCL12协同作用于CXCR4的变构调节。
FASEB J. 2017 Jul;31(7):3084-3097. doi: 10.1096/fj.201700013R. Epub 2017 Mar 30.
10
Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis.CXCL12表达的改变揭示了CXCR4在骨肉瘤原发肿瘤生长和转移中的双重作用。
J Cancer Res Clin Oncol. 2016 Aug;142(8):1739-50. doi: 10.1007/s00432-016-2185-5. Epub 2016 Jun 14.